Roivant Sciences (ROIV) Non-Current Assets (2021 - 2026)

Roivant Sciences (ROIV) reported Non-Current Assets of $153000.0 for Q1 2026, down 24.26% on a YoY basis from $202000.0 in Q1 2025, and down 100.0% quarter-over-quarter from $4.3 billion in Q4 2025.

Roivant Sciences (ROIV) Non-Current Assets (2021 - 2026) Analysis & Trends

Roivant Sciences has reported Non-Current Assets for 6 years, with the latest figure at $153000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets fell 24.26% year-over-year to $153000.0; the trailing twelve-month figure through Mar 2026 stood at $153000.0 (down 24.26% YoY), and the FY2026 full-year result was $153000.0, down 24.26% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $153000.0, down from $4.3 billion in the prior quarter.
  • The five-year high for Non-Current Assets was $4.3 billion in Q4 2025, with the low at $153000.0 in Q1 2026.
  • Historically, Non-Current Assets has averaged $837.3 million across 5 years, with a median of $513.9 million in 2023.
  • Annual changes were most pronounced in 2023 — Non-Current Assets soared 257.11% — and 2025, when it sank 98.6%.
  • Roivant Sciences' Non-Current Assets stood at $556.7 million in 2022, then soared by 257.11% to $2.0 billion in 2023, then increased by 17.73% to $2.3 billion in 2024, then surged by 83.05% to $4.3 billion in 2025, then plunged by 100.0% to $153000.0 in 2026.
  • The last three Non-Current Assets figures came in at $153000.0 (Q1 2026), $4.3 billion (Q4 2025), and $551.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Roivant Sciences 21.82 Bn 22.59 Bn - 153,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 153,000.00
Dec 31, 2025 4.28 Bn
Sep 30, 2025 550.95 Mn
Jun 30, 2025 416.85 Mn
Mar 31, 2025 202,000.00
Dec 31, 2024 2.34 Bn
Sep 30, 2024 404.91 Mn
Jun 30, 2024 494.95 Mn
Mar 31, 2024 14.42 Mn
Dec 31, 2023 1.99 Bn
Sep 30, 2023 513.92 Mn
Jun 30, 2023 575.49 Mn
Mar 31, 2023 591.02 Mn
Dec 31, 2022 556.73 Mn
Sep 30, 2022 500.67 Mn
Jun 30, 2022 560.96 Mn
Mar 31, 2022 438.61 Mn
Dec 31, 2021 511.84 Mn
Sep 30, 2021 547.15 Mn
Jun 30, 2021 397.09 Mn